Johnson S W, Hoffer B J, Freedman R
J Neurosci. 1986 Feb;6(2):572-80. doi: 10.1523/JNEUROSCI.06-02-00572.1986.
An anomaly in the experimental data underlying the theory that neuroleptics act by blockade of dopaminergic neurotransmission is the repeatedly demonstrated failure in several laboratories of parenterally administered neuroleptics to antagonize electrophysiologic actions of locally applied dopamine (DA) in striatum. This failure is enigmatic since many investigators have successfully demonstrated antagonism when both dopamine and neuroleptic are applied directly to striatal neurons by microiontophoresis. We used multibarrel micropipettes to pressure-eject DA agonists onto rat caudate neurons while observing the ability of parenterally administered haloperidol to block the inhibitory actions of dopaminergic agonists on neuronal activity. Experiments performed at times of maximal behavioural effect of haloperidol did not demonstrate agonist-antagonist interaction. This result has been obtained by four other teams of investigators. A variety of pharmacologic manipulations were employed to help solve this enigma. Acute treatment with reserpine and alpha-methyl-paratyrosine, performed to minimize any possible interference by endogenous DA, did not permit blockade of dopamine by haloperidol. To see if this failure of antagonism could be generalized to other DA agonists, apomorphine, amphetamine, and phencyclidine (PCP) were also investigated. Although the direct dopaminergic agonist apomorphine was not antagonized by haloperidol, the indirect DA agonist PCP was successfully antagonized. Amphetamine, which has both direct and indirect actions when applied locally, was not antagonized. Antagonism of direct agonists was demonstrated in rats with unilateral 6-hydroxydopamine-induced lesions of the nigrostriatal pathway. In these preparations, parenterally administered haloperidol reversed the receptor-mediated supersensitivity to the inhibitory effects of locally applied DA and apomorphine.(ABSTRACT TRUNCATED AT 250 WORDS)
神经阻滞剂通过阻断多巴胺能神经传递起作用这一理论所依据的实验数据中存在一个异常现象,即在多个实验室中反复证明,经肠胃外给予神经阻滞剂无法拮抗局部应用于纹状体的多巴胺(DA)的电生理作用。这一失败令人费解,因为许多研究人员通过微离子电泳将多巴胺和神经阻滞剂直接应用于纹状体神经元时,已成功证明存在拮抗作用。我们使用多管微量移液器将DA激动剂压力喷射到大鼠尾状核神经元上,同时观察经肠胃外给予氟哌啶醇阻断多巴胺能激动剂对神经元活动抑制作用的能力。在氟哌啶醇产生最大行为效应时进行的实验未显示激动剂 - 拮抗剂相互作用。其他四个研究团队也得到了这一结果。我们采用了多种药理学操作来帮助解开这个谜团。用利血平和α-甲基对酪氨酸进行急性处理,以尽量减少内源性DA的任何可能干扰,但这并未使氟哌啶醇能够阻断多巴胺。为了查看这种拮抗失败是否能推广到其他DA激动剂,还研究了阿扑吗啡、苯丙胺和苯环己哌啶(PCP)。虽然直接多巴胺能激动剂阿扑吗啡未被氟哌啶醇拮抗,但间接DA激动剂PCP却被成功拮抗。局部应用时具有直接和间接作用的苯丙胺未被拮抗。在单侧6-羟基多巴胺诱导黑质纹状体通路损伤的大鼠中证明了对直接激动剂的拮抗作用。在这些制剂中,经肠胃外给予氟哌啶醇可逆转受体介导的对局部应用DA和阿扑吗啡抑制作用的超敏反应。(摘要截短至250字)